Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasion-Reference-Cited by-同舟云学术

Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasion

Published:2015-08-10 Issue:17 Volume:35 Page:2156-2165
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Yen S-Y,Chen S-R,Hsieh J,Li Y-S,Chuang S-E,Chuang H-M,Huang M-H,Lin S-Z,Harn H-J,Chiou T-W

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2015277.pdf

Reference30 articles.

1. Jelsma R, Bucy PC . The treatment of glioblastoma multiforme of the brain. J Neurosurg 1967; 27: 388–400.

2. Tsitlakidis A, Foroglou N, Venetis CA, Patsalas I, Hatzisotiriou A, Selviaridis P . Biopsy versus resection in the management of malignant gliomas: a systematic review and meta-analysis. J Neurosurg 2010; 112: 1020–1032.

3. Giese A, Bjerkvig R, Berens ME, Westphal M . Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 2003; 21: 1624–1636.

4. Blacklock JB, Wright DC, Dedrick RL, Blasberg RG, Lutz RJ, Doppman JL et al. Drug streaming during intra-arterial chemotherapy. J Neurosurg 1986; 64: 284–291.

5. Shapiro WR, Green SB . Reevaluating the efficacy of intra-arterial BCNU. J Neurosurg 1987; 66: 313–315.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment;Advanced Drug Delivery Reviews;2022-09

2. Butylidenephthalide Abrogates the Snail-Induced Cancer Stemness in Oral Carcinomas;International Journal of Molecular Sciences;2022-05-31

3. Targeting the Axl and mTOR Pathway Synergizes Immunotherapy and Chemotherapy to Butylidenephthalide in a Recurrent GBM;Journal of Oncology;2022-05-18

4. Biodegradable controlled-release polymer containing butylidenephthalide to treat a recurrent cervical spine glioblastoma with promising result: a compassionate trial report;Anti-Cancer Drugs;2022-02-21

5. Interstitial Control-Released Polymer Carrying a Targeting Small-Molecule Drug Reduces PD-L1 and MGMT Expression in Recurrent High-Grade Gliomas with TMZ Resistance;Cancers;2022-02-18